Diabetes

Latest News


CME Content


One of the most enduring lessons from my training in the care of geriatric patients is the following maxim: “Treat every new symptom like a (possible) drug adverse effect until proven otherwise.”

Patients with type 2 diabetes eventually need insulin therapy as their disease progresses. The American Diabetes Association recommends basal-only therapy initially, with the addition of bolus meal-time insulin as needed. However, recent research supports starting patients on combined basal-bolus regimens to control blood sugar regardless of added hypoglycemia risk.

This study explores the impact of a Medicare Part D formulary tier change, specifically with respect to branded insulin products, on insulin adherence, hemoglobin A1C, and diabetes-related events in elderly diabetic beneficiaries strategies for selection of appropriate and cost-effective therapy will also be discussed.